期刊文献+

Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells 被引量:1

Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells
下载PDF
导出
摘要 Objective: To investigate the effect of activated protein C (APC) on inflammatory responses in human umbilical vein endothelial cells (HUVEC) stimulated with lipopolysaccharide (LPS). Methods: The second passage of collagenase digested HUVEC was divided into the following groups: serum free medium control group (SFM control), phosphate buffer solution control group (PBS control), LPS group with final concentration of 1 μg/ml (LPS group), APC group with final concentration of 7 μg/ml, Pre-APC group (APC pretreatment for 30 min prior to LPS challenge), and Post-APC group (APC administration 30 min after LPS challenge). Supernatant was harvested at 0, 4, 8, 12 and 24 h after LPS challenge. Interleukin-6 (IL-6) and Interleukin-8 (IL-8) levels were analyzed with ELISA. Cells were harvested at 24 h after LPS challenge, and total RNA was extracted. Mes-senger RNA levels for IL-6 and IL-8 were semi-quantitatively determined by RT-PCR. Results: Compared with control group, IL-6 and IL-8 levels steadily increased 4 to 24 h after LPS stimulation. APC treatment could increase LPS-induced IL-6 and IL-8 production. The mRNA levels of IL-6 and IL-8 exhibited a similar change. Conclusion: APC can further increase the level of IL-6 and IL-8 induced by LPS. The effect of these elevated cytokines is still under investigation. Objective: To investigate the effect of activated protein C (APC) on inflammatory responses in human umbilical vein endothelial cells (HUVEC) stimulated with lipopolysaccharide (LPS). Methods: The second passage of collagenase digested HUVEC was divided into the following groups: serum free medium control group (SFM control), phosphate buffer solution control group (PBS control), LPS group with final concentration of 1 μg/ml (LPS group), APC group with final concentration of 7 μg/ml, Pre-APC group (APC pretreatment for 30 min prior to LPS challenge), and Post-APC group (APC administration 30 min after LPS challenge). Supernatant was harvested at 0, 4, 8, 12 and 24 h after LPS challenge. Interleukin-6 (IL-6) and Interleukin-8 (IL-8) levels were analyzed with ELISA. Cells were harvested at 24 h after LPS challenge, and total RNA was extracted. Messenger RNA levels for IL-6 and IL-8 were semi-quantitatively determined by RT-PCR. Results: Compared with control group, IL-6 and IL-8 levels steadily increased 4 to 24 h after LPS stimulation. APC treatment could increase LPS-induced IL-6 and IL-8 production. The mRNA levels of IL-6 and IL-8 exhibited a similar change. Conclusion: APC can further increase the level of IL-6 and IL-8 induced by LPS. The effect of these elevated cytokines is still under investigation.
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第11期899-905,共7页 浙江大学学报(英文版)B辑(生物医学与生物技术)
关键词 活性蛋白C 白细胞间素 IL-6 IL-8 脓毒病 HUVEC Activated protein C (APC), Interleukin-6 (IL-6), Interleukin-8 (IL-8), Sepsis, Human umbilical vein endothelial cell(HUVEC)
  • 相关文献

参考文献10

  • 1Aderka, D,Le J,Vilcek, J.IL-6 inhibits lipopoly-saccharide-induced tumor necrosis factor production in cultured human monocytes[].U cells and in mice J Immunol.1989
  • 2Warren, B.L,Eid, A.,Singer, P,Pillay, S.S,Carl, P,NovakI.,Chalupa, P,Atherstone, A,Penzes, I,Kubler, A. et al.High-dose antithrombin III in severe sepsis a randomized controlled trial[].JAMA.2001
  • 3Abraham, E,Laterre, P.F,Garg, R.Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death[].N Engl J Med.2005
  • 4Bernard, G.R,Vincent, J.L,Laterre P.F.,LaRosa S.P.,Dhainaut J.F.,Lopez-Rodriguez A.,Steingrub, J.S.,Garber G.E.,Helterbrand J.D.,Ely, E.W. et al.Efficacy and safety of recombinant human activated protein C for severe sepsis[].N Engl J Med.2001
  • 5Hechtman, D.H,Cybulsky, M.I,Fuchs, H.J,Baker, J.B,Gimbrone, M.A.Jr.Intravascular IL-8 inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation[].J Immunol.1991
  • 6Smith, W.B,Gamble, J.R,Lewis, C.,Vadas, M.A.Chemotactic desensitization of neutrophils demonstrated interleukin-8 (IL-8)-dependent and IL-8-independent mechanisms of transmigration through cytokine-activated endothelium[].Immunology.1993
  • 7Lawson, J.H,Kalafatis, M,Stram, S,Mann, K.G.A model for the tissue factor pathway to thrombin[].J Bio Chem.1994
  • 8Hooper, W.C,Phillips, D.J,Renshaw, M.A,Evatt, B.L,Benson, J.M.The up-regulation of IL-6 and IL-8 in human endothelial cells by activated protein[].C J Im-munol.1998
  • 9Jaffe, E.A,Nachman, R.L,Becker, C.G,Minick, C.R.Culture of human endothelial cells derived from umbili-cal veins[].J Clin Invest.1973
  • 10Joyce, D.E,Gelbert, L.,Ciaccia, A.,DeHoff, B,Grinnell, B.W.Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflam-mation and apoptosis[].J Biol Chem.2001

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部